Status:

RECRUITING

Effects of SlimTrack® Platform on Diet Adherence, Anthropometry and Arterial Stiffness in Postmenopausal Women

Lead Sponsor:

Instituto de Cardiologia do Rio Grande do Sul

Conditions:

Menopause

Obesity

Eligibility:

FEMALE

45-60 years

Phase:

NA

Brief Summary

Introduction:The weight gain expected in the postmenopausal period has deleterious effects on the physical and mental health of the female population. Management of this situation strongly recommends ...

Detailed Description

Obesity is a chronic and multifactorial disease, physiologically characterized by excessive storage of body fat, which may have as a risk factor certain social reasons, lifestyle, inappropriate food c...

Eligibility Criteria

Inclusion

  • Inclusion Criteria
  • Menopause
  • Overweight
  • Obesity
  • Sedentary lifestyle
  • Exclusion Criteria:
  • Use of hormone therapy
  • Use of pharmacologial pshychiatric medication
  • Recent surgery (six months)
  • Recent (six months) cardiardiovascular events (myocardial infarction, stroke)
  • Adherence to diet in the last six months
  • Attending to psychoterapeutic proccess

Exclusion

    Key Trial Info

    Start Date :

    July 10 2024

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    November 30 2025

    Estimated Enrollment :

    64 Patients enrolled

    Trial Details

    Trial ID

    NCT06497946

    Start Date

    July 10 2024

    End Date

    November 30 2025

    Last Update

    August 23 2024

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Instituto de Cardiologia do Rio Grande do Sul

    Porto Alegre, Rio Grande do Sul, Brazil, 90620-130